Foot Pain From Cancer Treatment | Dr. Tom Biernacki Michigan

Quick answer: Most foot pain that begins during or after cancer treatment is chemotherapy-induced peripheral neuropathy, a nerve injury caused by specific drug classes rather than by the cancer itself. It is typically symmetrical, starts in the toes and spreads upward in a stocking pattern, and causes burning, tingling, numbness and sensitivity rather than mechanical pain. Other treatment-related causes include hand-foot syndrome, joint pain from aromatase inhibitors, steroid effects and swelling. The neuropathy often improves after treatment ends, but not always, and numb feet need active protection in the meantime.

Chemotherapy-induced peripheral neuropathy

Which treatments cause it

The risk is drug-specific rather than universal. The classes most associated with peripheral neuropathy are the platinum agents such as oxaliplatin and cisplatin, the taxanes such as paclitaxel and docetaxel, the vinca alkaloids such as vincristine, and the agents used in myeloma including bortezomib and thalidomide. Risk rises with cumulative dose, and it is higher in people who already have diabetes, a prior neuropathy, significant alcohol use or a B12 deficiency. Many other cancer treatments carry little or no neuropathy risk at all.

What it feels like

The pattern is the diagnostic clue. It affects both feet roughly equally, begins in the toes and works upward, and involves sensory symptoms far more than weakness: burning, pins and needles, numbness, a sensation of walking on sand or wearing invisible socks, and sometimes intense sensitivity where light touch from a bedsheet is painful. Oxaliplatin has a distinctive additional feature, a cold-triggered tingling in the hands, feet and throat that appears within hours to days of an infusion. Pain that is one-sided, purely mechanical, or clearly worse with activity and better with rest is usually something else.

How it changes over time

Symptoms usually appear after several cycles and track with cumulative dose. With platinum agents in particular, symptoms can continue to worsen for weeks to months after the final dose, a well-recognised pattern sometimes called coasting, which is unsettling if nobody has warned you about it. Over the following year many people improve substantially, though a meaningful proportion have some persistent symptoms long term. Numbness tends to be more stubborn than pain.

Report symptoms to your oncology team early and specifically rather than waiting until they are severe. Dose adjustment is the single most effective way to limit permanent nerve damage, and that decision belongs to your oncologist, who will weigh it against the cancer treatment plan. Describing what you can and cannot do, such as fastening buttons, feeling stairs underfoot, or walking without looking down, is more useful to them than rating pain out of ten.

Other treatment-related causes of foot pain

Hand-foot syndrome

Also called palmar-plantar erythrodysesthesia, this causes redness, swelling, tenderness, tingling and sometimes peeling or blistering on the soles and palms. It is associated with capecitabine, liposomal doxorubicin, fluorouracil and several targeted therapies. Unlike neuropathy it is a skin reaction, so the foot looks abnormal rather than feeling numb, and it improves with pressure reduction, emollients and dose changes managed by the oncology team.

Aromatase inhibitor joint and muscle pain

Women taking anastrozole, letrozole or exemestane commonly develop generalised joint stiffness and aching, and the feet are frequently involved. It is typically worst in the morning and after inactivity, affects multiple joints, and is a musculoskeletal rather than a nerve problem. It often responds well to graded exercise, weight management and mechanical support, and is one of the more treatable causes on this list.

Steroid effects

Long courses of corticosteroids can thin the protective fat pad under the heel and forefoot, contribute to bone loss, and in uncommon cases cause avascular necrosis, where the blood supply to a section of bone is compromised. Steroids also blunt the usual signs of infection, so a foot infection can look less impressive than it actually is.

Swelling and lymphedema

Swelling from lymph node surgery, radiation or the treatment itself changes how shoes fit, raises pressure on the skin, and makes the foot more vulnerable to breakdown. Footwear that fit before treatment frequently does not fit during it.

Reduced infection defences

During periods of low white cell counts, an ordinary blister, ingrown nail, callus crack or fungal infection carries far more consequence than usual. This is the main reason that routine, careful foot care becomes genuinely important during treatment rather than merely nice to have.

What actually helps the pain

Being straightforward about the evidence matters here, because this is an area with many marketed remedies and few proven ones.

• Duloxetine has the strongest supporting evidence for painful chemotherapy-induced neuropathy and is the agent most oncology guidelines identify first. It is prescribed and monitored by your oncology or primary care team.
• Other neuropathic agents such as gabapentin, pregabalin and nortriptyline are widely used, with less consistent trial support in this specific setting than in diabetic neuropathy. They are still reasonable to try under medical supervision.
• Topical treatments including compounded creams and lidocaine patches can help localised burning and carry few systemic effects.
• Exercise is one of the few interventions with reasonable evidence for both symptoms and balance. Walking, cycling and resistance work are all appropriate, adjusted to treatment tolerance.
• Physical and occupational therapy focused on balance retraining addresses the fall risk that comes with numb feet, which is often the more dangerous problem.
• Supplements including alpha-lipoic acid, acetyl-L-carnitine, vitamin E and glutamine have not held up well in trials, and acetyl-L-carnitine performed worse than placebo in one large study. Always clear supplements with your oncologist, since several interact with treatment.

Numb feet need protection, not just pain relief

When sensation is reduced, the foot loses its warning system. A shoe rubbing, a stone inside a sock, a hot bath, a heating pad or a blister can all cause damage that goes unnoticed until it is significant. Check both feet daily, including between the toes and the soles, using a mirror if needed. Never test water temperature with your feet. Avoid barefoot walking. Wear shoes with a wide toe box, a smooth interior and a secure fastening. Have nails and calluses managed professionally rather than cutting them yourself, particularly during low-count periods. If the skin does break down, our foot wound care service should see it early rather than after a week of home treatment.

How a podiatrist fits into your cancer care

• Baseline and repeat sensory testing so nerve loss is documented objectively rather than by recall, which also helps your oncology team judge progression.
• Distinguishing treatment-related neuropathy from mechanical foot problems, which do not stop happening during treatment and are often the easier thing to fix.
• Professional nail and callus care during low-immunity periods, when self-trimming carries real infection risk.
• Footwear assessment and custom orthotics to redistribute pressure, protect a thinned fat pad, and accommodate swelling.
• Bracing where weakness or drop foot has developed.
• Balance and fall-risk assessment through gait analysis, since numb feet plus deconditioning is a high fall-risk combination.
• Early wound assessment and rapid escalation when the skin breaks down.

When to seek urgent care

Contact your oncology team immediately, ahead of any routine podiatry appointment, for fever during a low-count period, spreading redness, a foot wound with drainage or odour, or sudden severe swelling in one leg. Also seek prompt assessment for new weakness or inability to lift the foot, rapidly worsening numbness, loss of bladder or bowel control alongside leg symptoms, or a wound on a numb foot at any stage. Infection during immunosuppression is a medical emergency and is treated as one.

Frequently asked questions

Will chemotherapy-induced neuropathy in my feet go away?

Often it improves substantially, but not always completely. Symptoms typically peak around the end of treatment or in the months after it, then improve gradually over the following six to twelve months. A meaningful proportion of people retain some symptoms longer term, and numbness tends to persist more than pain. Recovery is generally better with lower cumulative doses, which is why reporting symptoms early enough for dose adjustment to be considered matters so much.

Why did my symptoms get worse after chemotherapy finished?

This is a recognised phenomenon called coasting, seen most with platinum agents such as oxaliplatin. Nerve damage continues to declare itself for weeks to months after the last dose, so symptoms can worsen before they improve. It is unsettling but expected, and it does not mean the cancer has progressed. Report it to your oncology team so it is documented and so other causes can be excluded.

Is my foot pain from the cancer itself or from the treatment?

They usually look different. Treatment-related neuropathy is symmetrical, affects both feet, starts in the toes, and produces burning, tingling and numbness. Pain from cancer in the bone tends to be one-sided, focal, constant, and often worse at night and unrelated to activity. If your pain is on one side, pinpoint over a bone, or accompanied by a lump or swelling, it should be assessed rather than assumed to be neuropathy. Our page on whether foot pain can be cancer covers those warning features.

Can I do anything during infusions to prevent it?

Cooling and compression of the hands and feet during infusion have been studied for taxane-related neuropathy, with promising but not definitive results, and availability varies by centre. It is worth asking your oncology team whether they offer it. Exercise during treatment has reasonable supporting evidence and is safe for most patients. No supplement has been shown to prevent it reliably, and some interfere with treatment.

Is it safe to get a pedicure during cancer treatment?

Commercial pedicures are generally discouraged during active treatment, particularly during low white cell count periods. The combination of shared instruments, cuticle cutting, aggressive callus removal and reduced sensation creates real infection risk at a time when your defences are lowest. Care in a medical setting, using sterile instruments and coordinated with where you are in your treatment cycle, gives you the same result without that exposure.